Edeltraut Garbe

10.2k total citations · 2 hit papers
174 papers, 6.9k citations indexed

About

Edeltraut Garbe is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Edeltraut Garbe has authored 174 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cardiology and Cardiovascular Medicine, 31 papers in Epidemiology and 24 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Edeltraut Garbe's work include Pharmaceutical studies and practices (17 papers), Attention Deficit Hyperactivity Disorder (13 papers) and Health and Medical Studies (11 papers). Edeltraut Garbe is often cited by papers focused on Pharmaceutical studies and practices (17 papers), Attention Deficit Hyperactivity Disorder (13 papers) and Health and Medical Studies (11 papers). Edeltraut Garbe collaborates with scholars based in Germany, Canada and Netherlands. Edeltraut Garbe's co-authors include Frank Andersohn, Samy Suissa, R Schade, Wilhelm Haverkamp, Tania Schink, Niklas Schmedt, Rafael Mikolajczyk, Andreas Klimpel, Elisabeth Bronder and Ingo Langner and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Edeltraut Garbe

171 papers receiving 6.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation

2007 490 citations R Schade, Frank Andersohn et al. profile →
Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data

2017 341 citations Michèle Bally, Nandini Dendukuri et al. BMJ profile →

Peers

Countries citing papers authored by Edeltraut Garbe

Since Specialization

Citations

This map shows the geographic impact of Edeltraut Garbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edeltraut Garbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edeltraut Garbe more than expected).

Fields of papers citing papers by Edeltraut Garbe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edeltraut Garbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edeltraut Garbe. The network helps show where Edeltraut Garbe may publish in the future.

Co-authorship network of co-authors of Edeltraut Garbe

This figure shows the co-authorship network connecting the top 25 collaborators of Edeltraut Garbe. A scholar is included among the top collaborators of Edeltraut Garbe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edeltraut Garbe. Edeltraut Garbe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands 2023 ·Respiratory Research ·Karin M. A. Swart, (unknown), (unknown), Fernie J. A. Penning‐van Beest, Camilla Bengtsson, Muriel Lobier, Fabian Hoti, Dina Vojinović, (unknown), Kirsty Rhodes, Edeltraut Garbe, Ron M. C. Herings, Clémentine Nordon, Sami O. Simons	24
2	Antidepressants and the risk of death in older patients with depression: A population-based cohort study 2019 ·PLoS ONE ·Bianca Kollhorst, Kathrin Jobski, Jutta Krappweis, Tania Schink, Edeltraut Garbe, Niklas Schmedt	13
3	The contribution of comorbidities to mortality in hospitalized patients with heart failure 2018 ·Clinical Research in Cardiology ·Oliver Riedel, Christoph Ohlmeier, (unknown), Albrecht Elsässer, David Vizcaya, Alexander Michel, Sveja Eberhard, (unknown), (unknown), Edeltraut Garbe	25
4	Risk of acute myocardial infarction during use of individual NSAIDs: A nested case-control study from the SOS project 2018 ·PLoS ONE ·Gwen Masclee, Huub Straatman, Andrea Arfè, Jordi Castellsagué, Edeltraut Garbe, Ron M. C. Herings, Bianca Kollhorst, S Lucchi, Susana Perez‐Gutthann, Silvana Romio, R Schade, Tania Schink, Martijn J. Schuemie, Lorenza Scotti, Cristina Varas‐Lorenzo, Vera E. Valkhoff, Marco Villa, Miriam Sturkenboom	44
5	The Risk of Ischemic Cardio- and Cerebrovascular Events Associated with Oxycodone–Naloxone and Other Extended-Release High-Potency Opioids: A Nested Case–Control Study 2017 ·Drug Safety ·Kathrin Jobski, Bianca Kollhorst, Edeltraut Garbe, Tania Schink	10
6	Extent and Risks of Antipsychotic Off-Label Use in Children and Adolescents in Germany Between 2004 and 2011 2017 ·Journal of Child and Adolescent Psychopharmacology ·Carsten Schröder, Michael Dörks, Bianca Kollhorst, Tilo Blenk, Regina Dittmann, Edeltraut Garbe, Oliver Riedel	10
7	Sodium-Glucose Co-Transporter-2 (Sglt-2) Inhibitors And The Risk of Fractures of The Upper or Lower Limb In Patients With Type 2 Diabetes: A Nested-Case Control Study 2017 ·Value in Health ·Niklas Schmedt, Frank Andersohn, Jochen Walker, Edeltraut Garbe	1
8	Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data breakdown → 2017 ·BMJ ·Michèle Bally, Nandini Dendukuri, Benjamin Rich, Lyne Nadeau, Arja Helin‐Salmivaara, Edeltraut Garbe, James M. Brophy	341
9	Characterization of new users of cilostazol in the United Kingdom, Spain, Sweden, and Germany 2016 ·Pharmacoepidemiology and Drug Safety ·Jordi Castellsagué, Brian Calingaert, Beatriz Poblador‐Plou, Maria Giner‐Soriano, Marie Linder, (unknown), Cristina Varas‐Lorenzo, Alejandro Arana, (unknown), Alexandra Prados‐Torres, Francisca González‐Rubio, Albert Roso‐Llorach, Anna Citarella, Edeltraut Garbe, Tilo Blenk, Susana Perez‐Gutthann	1
10	Perkutane koronare Interventionen 2016 ·Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz ·Christoph Ohlmeier, (unknown), (unknown), Rafael Mikolajczyk, Rüdiger Blindt, Dirk Horenkamp‐Sonntag, Roland Linder, Edeltraut Garbe	4
11	Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case–Control Surveillance Study 2014 ·European Journal of Clinical Pharmacology ·Matthias Huber, Frank Andersohn, Giselle Sarganas, Elisabeth Bronder, Andreas Klimpel, Michael Thomae, (unknown), Reinhold Kreutz, Edeltraut Garbe	70
12	Background paper to the recommendation for routine rotavirus vaccination of infants in Germany 2013 ·Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz ·Judith Koch, Miriam Wiese‐Posselt, Cornelius Remschmidt, Ole Wichmann, (unknown), Edeltraut Garbe, Hartmut Hengel, Joerg J Meerpohl, Andreas Mas Marques, H Oppermann, Eva Hummers, Rüdiger von Kries, Thomas Mertens	26
13	Epidemiology of symptomatic drug-induced long QT syndrome and torsade de pointes in Germany 2013 ·EP Europace ·Giselle Sarganas, Edeltraut Garbe, Andreas Klimpel, Rudolf Hering, Elisabeth Bronder, W. Haverkamp	105
14	Population-based analysis of non-steroidal anti-inflammatory drug use among children in four European countries in the SOS project: what size of data platforms and which study designs do we need to assess safety issues? 2013 ·BMC Pediatrics ·Vera E. Valkhoff, R Schade, Geert W. ‘t Jong, Silvana Romio, Martijn J. Schuemie, Andrea Arfè, Edeltraut Garbe, Ron M. C. Herings, S Lucchi, Gino Picelli, Tania Schink, Huub Straatman, Marco Villa, Ernst J. Kuipers, Miriam Sturkenboom	29
15	Risk of upper gastrointestinal complications associated with use of individual non-steroidal anti-inflammatory drugs in the SOS Project. 2012 ·Pharmacoepidemiology and Drug Safety ·S Lucchi, (unknown), Bianca Kollhorst, Tania Schink, Edeltraut Garbe, Andrea Arfè, Jordi Castellsagué, RM Herings, (unknown), Silvana Romio, Francesco Salvo, R Schade, (unknown), Huub Straatman, Frantz Thiessard, Miriam Sturkenboom, Marco Villa	2
16	Drug Treatment Patterns of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents in Germany: Results from a Large Population-Based Cohort Study 2012 ·Journal of Child and Adolescent Psychopharmacology ·Edeltraut Garbe, Rafael Mikolajczyk, Tobias Banaschewski, Ulrike Petermann, Franz Petermann, (unknown), Ingo Langner	55
17	Prescribing of Potentially Inappropriate Medications for the Elderly 2012 ·Deutsches Ärzteblatt international ·Ute Amann, Niklas Schmedt, Edeltraut Garbe	68
18	Age-Specific Prevalence, Incidence of New Diagnoses, and Drug Treatment of Attention-Deficit/Hyperactivity Disorder in Germany 2012 ·Journal of Child and Adolescent Psychopharmacology ·Christina Lindemann, Ingo Langner, (unknown), Tobias Banaschewski, (unknown), Ulrike Petermann, Franz Petermann, (unknown), Edeltraut Garbe, Rafael Mikolajczyk	37
19	Oral progestogen-only contraceptives and cardiovascular risk: Results from the Transnational Study on Oral Contraceptives and the Health of Young Women 1999 ·The European Journal of Contraception & Reproductive Health Care ·Lothar Heinemann, A. Aßmann, Thai DoMinh, Edeltraut Garbe	83
20	Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. 1997 ·American Journal of Ophthalmology ·Edeltraut Garbe, Jacques LeLorier, J-F Boivin, Samy Suissa	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact